Immunoexpression of TTF-1 and Ki-67 in a coexistent anaplastic and follicular thyroid cancer with rare long-life surviving

Folia Histochemica et Cytobiologica

Volumn 46, Issue 4, 2008, Pages 461-464

  Ali Ziad, El ^a   Ruchala, Marek ^a   Breborowicz, Jan ^a   Gembicki, Maciej ^a   Sowinski, Jerzy ^a   Grzymislawski, Marian ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Anaplastic thyroid cancer; Follicular thyroid cancer; Ki 67; Long survival; TTF 1

Indexed keywords

KI 67 ANTIGEN; LEVOTHYROXINE; THYROGLOBULIN; THYROID TRANSCRIPTION FACTOR 1; THYROTROPIN; NUCLEAR PROTEIN; THYROID NUCLEAR FACTOR 1; TRANSCRIPTION FACTOR;

AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; ECHOGRAPHY; ESOPHAGITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LARYNGOSCOPY; LYMPH NODE DISSECTION; NECK TUMOR; PHYSICAL EXAMINATION; PROTEIN EXPRESSION; RADIOGRAPHY; SURVIVAL TIME; THYROGLOBULIN BLOOD LEVEL; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TRACHEA DISEASE; TRACHEOSTOMY; TUMOR VOLUME; VOCAL CORD PARALYSIS; ADENOCARCINOMA; METABOLISM; PATHOLOGY; SURVIVAL; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NUCLEAR PROTEINS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 60549116674     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0071-y     Document Type: Article

References (17)

1. Katoh R, Kawaoi A, Miyagi E, Li X, Suzuki K, Nakamura Y, Kakudo K. Thyroid Transcription Factor-1 in Normal, Hyperplastic, and Neoplastic Follicular Thyroid Cells Examined by Immunohistochemistry and Nonradioactive In Situ Hybridisation. Mod. Pathol. 2000; 13:570-576.
2. Lanzafame S, Caltabiano R, Puzzo L, Cappellani A. Thyroid transcription factor 1 (TTF1) and p63 expression in two primary thyroid papillary carcinomas of branchial cleft cysts. Virchows Arch. 2006;49:129-133.
3. Wiseman SM, Loree TR, Hicks WL Jr, Rigual NR, Winston JS, Tan D, Anderson GR, Stoler DL. Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation utilizing the inter-simple sequence repeat polymerase chain reaction. Arch Otolaryngol Head Neck Surg. 2003;129:96-100.
4. Hunt JL, Tometsko M, LiVolsi VA, Swalsky P, Finkelstein SD, Barnes EL. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol. 2003;27:1559-1564.
5. Are C, Shaha A Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment Approaches. Ann Surg Oncol. 2006;13:453-464.
6. Wiseman SM, Loree TR, Rigual NR, Hicks WL Jr, Douglas WG, Anderson GR, Stoler DL: Anaplastic transformation of thyroid cancer: review of clinical, pathological, and molecular evidence provides new insights into disease biology and future therapy. Head Neck. 2003;25:662-670.
7. Passler C, Scheuba C, Prager G, Kaserer K, Flores JA, Vierhapper H, Niederle B. Anaplastic (undifferentiated) thyroid carcinoma ATC). A retrospective analysis. Langenbeck's Arch Surg. 1999;384:284-293.
8. Zhang P, Zuo H, Nakamura Y, Nakamura M, Wakasa T, Kadubo K Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Path Int. 2006;56:240-245.
9. Katoh R, Bray CE, Suzuki K, Komiyama A, Hemmi A, Kawaoi A, Oyama T, Sugai T, Sasou S. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum Pathol. 1995;26:139-156.
10. Hunt JL, Tometsko M, LiVolsi VA, Swalsky P, Finkelstein SD, Barnes EL. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol. 2003;27:1559-1564.
11. Wiseman SM, Loree TR, Hicks WL Jr, Rigual NR, Winston JS, Tan D, Anderson GR, Stoler DL. Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation utilizing the inter-simple sequence repeat polymerase chain reaction. Arch Otolaryngol Head Neck Surg. 2003;129:96-100.
12. Galera-Davidson H, Bibbo M, Dytch HE, González-Cámpora R, Fernández A, Wied GL. Nuclear DNA in anaplastic thyroid carcinoma with a differentiated component. Histopathology. 1987;11:715-722.
13. Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, Carcangiu ML. Downregulation of p27kip1 and Ki67/Mib1 labeling Index Support the classification of Thyroid Carcinoma Into Prognostically Relevant Categories. Am J Surg Path. 1999;23:678-685.
14. Ito Y, Yoshuda H, Nakano K, Ito Y, Yoshida H, Nakano K, Kobayashi K, Yokozawa T, Hirai K, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A. Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues. Int J Mol Med. 2002;9: 373-376.
15. Lam, KL, Lo C, Chan K, Wan K. Insular and anaplastic carcinoma of the thyroid. A 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg. 2000;231:439-338.
16. Stoler DL, Datta RV, Charles MA, Block AW, Brenner BM, Sieczka EM, Hicks WL Jr, Loree TR, Anderson GR. Genomic instability measurement in the diagnosis of thyroid neoplasms. Head Neck. 2002;24:290-305.
17. Gupta S, Patel A, Folstad A, Fenton C, Dinauuer CA, Tuttle RM, Contran R, Francis GL. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. JCEM. 2001;86:1346-1354.